Molecular Templates, Inc.
OTC: MTEM0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Eric E. Poma
- Employees
- 62
- Headquarters
- Austin, United States
- IPO year
- 2005
- Market cap
- $658.0
- Website
- https://www.mtem.com
Loading MTEM…
Loading profile data…Frequently asked questions about MTEM
What does Molecular Templates, Inc. (MTEM) do?
Molecular Templates, Inc. (MTEM) is a clinical-stage biopharmaceutical firm dedicated to the identification and progression of biological therapies for oncology and other significant health conditions. The company's core development strategy relies on its unique engineered toxin body (ETB) drug platform to construct a robust pipeline of treatmen...
Where does MTEM trade?
Molecular Templates, Inc. (MTEM) trades on the Other OTC.
What sector is MTEM in?
Molecular Templates, Inc. (MTEM) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Molecular Templates, Inc.?
Eric E. Poma is the chief executive officer of Molecular Templates, Inc. (MTEM).
Where is Molecular Templates, Inc. headquartered?
Molecular Templates, Inc. is headquartered in United States.
Does MTEM pay a dividend?
Molecular Templates, Inc. (MTEM) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MTEM go public?
Molecular Templates, Inc. (MTEM) completed its initial public offering in 2005.